Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 6, 2010, Pages 1457-1463

  Margaritora, S ^a   Cesario, A ^a,b   Cusumano, G ^a   Cafarotti, S ^a   Corbo, G M ^c   Ferri, L ^b   Ceppi, M ^d   Meacci, E ^a   Valente, S ^c   D'Angelillo, R M ^e   Russo, P ^d   Porziella, V ^a   Bonassi, S ^b   Pasqua, F ^f   Sterzi, S ^g   Granone, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e Rehabilitative Pneumology ^*  (Italy)

^f Rehabilitative Pneumology   (Italy)

^g UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; GEMCITABINE;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD GAS ANALYSIS; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; TREND STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 77952320364     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.10.023     Document Type: Article

References (27)

1. ASCO. Clinical practice guidelines for the treatment of unresectable NSCLC. J Clin Oncol 15 (1997) 2996-3018
2. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
3. Milstein D., Kuten A., Saute M., Best L.A., Daoud K., Zen-Al-Deen I., et al. Preoperative concurrent chemoradiotherapy for unresectable stage III non small cell lung cancer. Int J Radiat Oncol Biol Phys 34 (1996) 1125-1132
4. Trodella L., Granone P., Valente S., Margaritora S., Macis G., Cesario A., et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non small cell lung cancer: long term results according to downstaging. Ann Oncol 15 (2004) 389-398
5. Galetta D., Cesario A., Margaritora S., Porziella V., Macis G., D'Angelillo R.M., et al. Enduring challenge in treatment of NSCLC with clinical stage IIIB: results of a trimodality approach. Ann Thorac Surg 76 (2003) 1802-1808 discussion 1808-9
6. Granone P., Cesario A., Margaritora S., Galetta D., Valente S., Corbo G.M., et al. Morbidity after induction therapy and surgery in NSCLC: focus on pulmonary function. Lung Cancer 36 (2002) 219-220
7. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 352 (1998) 257-263
8. Doddoli C., Thomas P., Thirion X., Serée Y., Giudicelli R., and Fuentes P. Postoperative complication in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg 20 (2001) 385-390
9. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for NSCLC. Ann Thorac Surg 72 (2001) 885-888
10. Takeda S., Funakoshi Y., Kadota Y., Koma M., Maeda H., Kawamura S., et al. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?. Ann Thorac Surg 82 (2006) 232-236
11. Margaritora S., Cesario A., Galetta D., D'Andrilli A., Macis G., Mantini G., et al. Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?. Eur J Cardiothorac Surg 19 (2001) 894-898
12. Graham A.N., Chan K.J., Pastorino U., and Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 117 (1999) 246-251
13. Leyland A.H., and Golstein H. Multilevel modelling of health statistics (2001), John Wiley, Chichester (England)
14. STATA statistical software release 5.0. College Station (TX).
15. Leo F., Solli P., Spaggiari L., Veronesi G., de Braud F., Leon M.E., et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?. Ann Thorac Surg 77 (2004) 260-265
16. Maas K.W., van der Lee I., Bolt K., Zanen P., Lammers J.W., and Schramel F.M. Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment. Lung Cancer 41 (2003) 345-351
17. Abratt R.P., and Willcox P.A. The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys 31 (1995) 915-919
18. Borst G.R., De Jaeger K., Belderbos J.S., Burgers S.A., and Lebesque J.V. Pulmonary function changes after radiotherapy in NSCLC patients with long term disease free survival. Int J Radiat Oncol Biol Phys 62 (2005) 639-644
19. Gopal R., Tucker S.L., Komaki R., Liao Z., Forster K.M., Stevens C., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113
20. Abratt R.P., and Morgan G.W. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 35 (2002) 103-109
21. Kim T.H., Cho K.H., Pyo H.R., Lee J.S., Zo J.I., Lee D.H., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215 Epub 2005 Feb 9
22. Dimopoulou I., Galani H., Dafni U., Samakovii A., Roussos C., and Dimopoulos M.A. A prospective study of pulmonary function in patients treated with Paclitaxel and Carboplatin. Cancer 94 (2002) 452-458
23. Dimopoulou I., Efstathiou E., Samakovli A., Dafni U., Moulopoulos L.A., Papadimitriou C., et al. A prospective study on lung toxicity in patients treated with Gemcitabine and Carboplatin: clinical radiological and functional assessment. Ann Oncol 15 (2004) 1250-1255
24. Videtic G.M., Stitt L.W., Ash R.B., Truong P.T., Dar A.R., Yu E.W., et al. Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. Lung Cancer 43 (2004) 159-166
25. Baser S., Shannon V.R., Eapen G.A., Jimenez C.A., Onn A., Lin E., et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 130 (2006) 1784-1790
26. Cesario A., Ferri L., Galetta D., Pasqua F., Bonassi S., Clini E., et al. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer 57 (2007) 175-180
27. Cesario A., Ferri L., Galetta D., Cardaci V., Biscione G., Pasqua F., et al. Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer 57 (2007) 118-119